SCHEMBL9978366

SCHEMBL9978366

NC(=O)Oc1cncnc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
HCAR2 Q8TDS4 1/20 0.46
KIF11 P52732 1/20 0.37
SIRT2 Q8IXJ6 3/20 0.34
SIRT1 Q96EB6 3/20 0.34
SIRT3 Q9NTG7 3/20 0.34
F7 P08709 1/20 0.34
F3 P13726 1/20 0.34
SARM1 Q6SZW1 1/20 0.34
SIRT6 Q8N6T7 1/20 0.34
SIRT5 Q9NXA8 1/20 0.34
SIRT4 Q9Y6E7 1/20 0.34
IKBKB O14920 1/20 0.33
CHUK O15111 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
ADORA3 P0DMS8 1/20 0.31
TSHR P16473 1/20 0.31
MC4R P32245 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9572445 0.81 KMT2A (0.58) MEN1KMT2ASIRT2SIRT1SIRT3
SCHEMBL187133 0.78 HCAR2 (0.54) MEN1KMT2AHCAR2BCAT2KDM4E
Methylamine SCHEMBL27659540 0.77 LMNA (0.43) MEN1KMT2AHCAR2KDM4E
SCHEMBL28284702 0.77 SIRT2 (0.54) MEN1KMT2ASIRT2SIRT1SIRT3
SCHEMBL1921878 0.76 LMNA (0.46) MEN1KMT2AHCAR2KDM4ENPC1
SCHEMBL29225190 0.74 KMT2A (0.45) MEN1KMT2AKIF11SIRT6MKNK1
SCHEMBL28029118 0.74 LMNA (0.45) MEN1KMT2AHCAR2KDM4ENPC1
SCHEMBL283911 0.74 KMT2A (0.55) MEN1KMT2ASIRT2SIRT1SIRT3
SCHEMBL29786195 0.74 KMT2A (0.55) MEN1KMT2ASIRT2SIRT1SIRT3
SCHEMBL28940984 0.74 APLNR (0.46) MEN1KMT2AMKNK1MKNK2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117813293-A Urea derivatives useful for the treatment of cancer 蝎子疗法股份有限公司 2024-04-02 CN disclosed
CN-115697978-A Method for preparing methyl {4,6-diamino-2- [ 5-fluoro-1- (2-fluorobenzyl) -1H-pyrazolo [3,4-b ] pyridin-3-yl ] pyrimidin-5-yl } carbamate 阿德弗里奥药品有限责任公司 2023-02-03 CN disclosed
EP-2575473-A1 SOLUBLE GUANYLATE CYCLASE ACTIVATORS Merck Sharp & Dohme Corp. (US) 2013-04-10 EP disclosed
WO-2011149921-A1 SOLUBLE GUANYLATE CYCLASE ACTIVATORS MERCK SHARP & DOHME CORP. (US) 2011-12-01 WO disclosed
EP-0142040-A2 Substituted pyrimidines BAYER AG (DE) 1985-05-22 EP disclosed